Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 435

1.

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma.

Sabbatino F, Wang Y, Scognamiglio G, Favoino E, Feldman SA, Villani V, Flaherty KT, Nota S, Giannarelli D, Simeone E, Anniciello AM, Palmieri G, Pepe S, Botti G, Ascierto PA, Ferrone CR, Ferrone S.

J Natl Cancer Inst. 2016 Feb 5;108(7). pii: djv435. Print 2016 Jul.

PMID:
26851802
2.

Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma.

Aquino G, Franco R, Sabatino R, Mantia EL, Scognamiglio G, Collina F, Longo F, Ionna F, Losito NS, Liguori G, Botti G, Cantile M.

Am J Cancer Res. 2015 Sep 15;5(10):3042-55. eCollection 2015.

3.

LncRNA HOTAIR as prognostic circulating marker and potential therapeutic target in patients with tumor diseases.

Botti G, Marra L, Malzone MG, Anniciello A, Botti C, Franco R, Cantile M.

Curr Drug Targets. 2015 Dec 9. [Epub ahead of print]

PMID:
26648066
4.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M, Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Arthur GM, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2015 Nov 30;13:374. doi: 10.1186/s12967-015-0736-1.

5.

Immune-phenotypical markers for the differential diagnosis of melanocytic lesions.

Botti G, Marra L, Anniciello A, Scognamiglio G, Gigantino V, Cantile M.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9742-51. eCollection 2015. Review.

6.

Facelift 2015.

Botti C, Botti G.

Facial Plast Surg. 2015 Oct;31(5):491-503. doi: 10.1055/s-0035-1566270. Epub 2015 Nov 18.

PMID:
26579864
7.

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.

Collina F, Di Bonito M, Li Bergolis V, De Laurentiis M, Vitagliano C, Cerrone M, Nuzzo F, Cantile M, Botti G.

Biomed Res Int. 2015;2015:158682. doi: 10.1155/2015/158682. Epub 2015 Oct 4.

8.

Correction: Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.

Zito Marino F, Liguori G, Aquino G, La Mantia E, Bosari S, Ferrero S, Rosso L, Gaudioso G, De Rosa N, Scrima M, Martucci N, La Rocca A, Normanno N, Morabito A, Rocco G, Botti G, Franco R.

PLoS One. 2015 Oct 21;10(10):e0141521. doi: 10.1371/journal.pone.0141521. eCollection 2015. No abstract available.

9.

PD-L1 expression as a potential predictive biomarker.

Fusi A, Festino L, Botti G, Masucci G, Melero I, Lorigan P, Ascierto PA.

Lancet Oncol. 2015 Oct;16(13):1285-7. doi: 10.1016/S1470-2045(15)00307-1. No abstract available.

PMID:
26433815
10.

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.

Zito Marino F, Liguori G, Aquino G, La Mantia E, Bosari S, Ferrero S, Rosso L, Gaudioso G, De Rosa N, Scrima M, Martucci N, La Rocca A, Normanno N, Morabito A, Rocco G, Botti G, Franco R.

PLoS One. 2015 Sep 30;10(9):e0139264. doi: 10.1371/journal.pone.0139264. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0141521. Marino, Federica Zito [corrected to Zito Marino, Federica].

11.

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial.

Avallone A, Pecori B, Bianco F, Aloj L, Tatangelo F, Romano C, Granata V, Marone P, Leone A, Botti G, Petrillo A, Caracò C, Iaffaioli VR, Muto P, Romano G, Comella P, Budillon A, Delrio P.

Oncotarget. 2015 Oct 6;6(30):30394-407. doi: 10.18632/oncotarget.4724.

12.

Reply: Midface Rejuvenation: A Critical Evaluation of a 7-Year Experience.

Pascali M, Botti C, Cervelli V, Botti G.

Plast Reconstr Surg. 2015 Dec;136(6):840e-2e. doi: 10.1097/PRS.0000000000001751. No abstract available.

PMID:
26284794
13.

Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.

Pasquale R, Fenizia F, Esposito Abate R, Sacco A, Esposito C, Forgione L, Rachiglio AM, Bevilacqua S, Montanino A, Franco R, Rocco G, Botti G, Denis MG, Morabito A, De Luca A, Normanno N.

Pharmacogenomics. 2015;16(10):1135-48. doi: 10.2217/pgs.15.45. Epub 2015 Aug 7.

PMID:
26249748
14.

Atypical amplification of chromosome region 22q12 in melanoma: A case report.

Liguori G, Cantile M, Collina F, Marra L, DE Chiara A, Franco R, Caraglia M, Botti G, D'Andrea M, Nicoletti GF.

Oncol Lett. 2015 Jul;10(1):349-353. Epub 2015 Apr 27.

15.

Chin Microgenia: A Clinical Comparative Study.

Bertossi D, Galzignato PF, Albanese M, Botti C, Botti G, Nocini PF.

Aesthetic Plast Surg. 2015 Oct;39(5):651-8. doi: 10.1007/s00266-015-0518-4. Epub 2015 Jul 1.

PMID:
26130400
16.

Determination of whether screening tests for chronic atrophic gastritis really has a positive predictive value.

Di Paola F, D'Angelo V, Tatangelo F, Barchiesi V, Rizzo M, Cantile M, Botti G, Cavalcanti E.

Mol Med Rep. 2015 Sep;12(3):3521-4. doi: 10.3892/mmr.2015.3872. Epub 2015 Jun 2.

PMID:
26035809
17.

Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene.

Malzone MG, Campanile AC, Losito NS, Longo F, Perri F, Caponigro F, Schiavone C, Ionna F, Maiello F, Martinuzzi C, Nasti S, Botti G, Fulciniti F.

Diagn Cytopathol. 2015 Aug;43(8):654-8. doi: 10.1002/dc.23275. Epub 2015 May 21.

PMID:
25995191
18.

AXL is an oncotarget in human colorectal cancer.

Martinelli E, Martini G, Cardone C, Troiani T, Liguori G, Vitagliano D, Napolitano S, Morgillo F, Rinaldi B, Melillo RM, Liotti F, Nappi A, Bianco R, Berrino L, Ciuffreda LP, Ciardiello D, Iaffaioli V, Botti G, Ferraiolo F, Ciardiello F.

Oncotarget. 2015 Sep 15;6(27):23281-96.

19.

Synchronous Pleomorphic Adenoma and Invasive Ductal Carcinoma in Distinct Breasts.

Di Bonito M, Cantile M, Cerrone M, Liguori G, Botti G.

Breast J. 2015 Jul-Aug;21(4):428-30. doi: 10.1111/tbj.12426. Epub 2015 May 3. No abstract available.

PMID:
25940209
20.

Midface rejuvenation: a critical evaluation of a 7-year experience.

Pascali M, Botti C, Cervelli V, Botti G.

Plast Reconstr Surg. 2015 May;135(5):1305-16. doi: 10.1097/PRS.0000000000001189.

PMID:
25919244
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk